ArticleBioMed research international2026
Duration and Predictors of "In-Need" Contraceptive Discontinuation in Ethiopia: A Competing Risks Analysis Using the Fine-Gray Subdistribution Hazards Model.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Duration and Predictors of "In-Need" Contraceptive Discontinuation in Ethiopia: A Competing Risks Analysis Using the Fine-Gray Subdistribution Hazards Model.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundContraceptive discontinuation while a need for pregnancy prevention persists, often termed "in-need" discontinuation, remains a significant barrier to achieving reproductive health goals in Ethiopia. Traditional survival analyses often overestimate this risk by failing to account for competing events, such as discontinuation due to an intentional desire for pregnancy.
methodsThis study utilized nationally representative data from the 2016 Ethiopian Demographic and Health Survey (EDHS). A total of 1617 contraceptive episodes among currently married women were analyzed. To identify predictors of "in-need" discontinuation while strictly accounting for the competing risk of "desire for pregnancy," a Fine-Gray subdistribution hazards model was employed as the primary inferential framework.
resultsThe overall 12-month-adjusted cumulative incidence of "in-need" discontinuation was heterogeneous across sociodemographic strata. Women in the 35-49 age cohort exhibited a significantly higher subdistribution hazard (2.91%) compared with those aged 15-24 (1.58%; aSHR: 1.85; 95% CI: 1.26-2.71). Secondary education was protective, reducing the 12-month incidence to 1.27% compared with 1.85% for those with no formal education (aSHR: 0.62; 95% CI: 0.40-0.96). Conversely, women engaged in manual labor faced an increased probability of discontinuation (1.97%) compared with professional workers (1.29%; aSHR: 1.56; 95% CI: 1.08-2.25). Notably, women with undecided fertility preferences showed the highest persistence, with a 12-month probability of only 1.03% (aSHR: 0.55; 95% CI: 0.32-0.93). Religious affiliation remained a strong predictor, with Catholic users exhibiting a higher subdistribution hazard (aSHR: 4.65; 95% CI: 2.06-10.49).
conclusion"In-need" discontinuation in Ethiopia is driven by a complex interplay of age, educational attainment, and occupational physical demands. The finding that older and less-educated women are at higher risk suggests that national family planning programs should move beyond adolescent-focused strategies to include targeted clinical counseling for long-term users. Furthermore, the economic impact of side effects on manual laborers necessitates more flexible, community-based follow-up care to ensure contraceptive security for Ethiopia's most economically vulnerable women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.